Quick answers
- What is Avtozma?
- Avtozma is a brand name of Tocilizumab, a prescription medicine. The FDA NDC Directory lists 4 Avtozma products in 4 strengths and forms.
- Who makes Avtozma?
- Celltrion Inc holds the FDA application for Avtozma (BLA761420, approved January 24, 2025).
- Is there a generic or store brand of Avtozma?
- Yes. The FDA NDC Directory lists 6 other products with the same active ingredients, strength and form as a Avtozma product. Ask your pharmacist whether one is right for you.
- Has Avtozma been recalled?
- No recall linked to Avtozma products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Avtozma is
Each Avtozma product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Tocilizumab · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| tocilizumab 162 mg/0.9 mL injection, solution (subcutaneous) | Avtozma | 6 products, 2 companies | — |
| tocilizumab 200 mg/10 mL injection, solution (intravenous) | Avtozma | None listed | — |
| tocilizumab 400 mg/20 mL injection, solution (intravenous) | Avtozma | None listed | — |
| tocilizumab 80 mg/4 mL injection, solution (intravenous) | Avtozma | None listed | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tocilizumab →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
Companies that list Avtozma
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Avtozma products.
- CELLTRION USA, Inc.4 products
Recalls
No recall linked to Avtozma products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.